NCT02814591UNKNOWNanonymous

Development of a Novel, Safe Method for the Non-invasive Assessment of Human Bone Quality, In Vivo, Using Spatially Offset Raman Spectroscopy

Sponsor

Source record

University College, London

Phase

Source record

Not classified

Modality

AI-normalized

medical device

Target

AI-normalized

spatially offset Raman spectrometer (SORS)

Indication / condition

AI-normalized

Osteoarthritis

Intervention

Source record

spatially offset Raman spectrometer (SORS)

Source & freshness

Source record

NCT ID

NCT02814591

Original source

ClinicalTrials.gov

Source last updated

Nov 23, 2022

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02814591

Title

Development of a Novel, Safe Method for the Non-invasive Assessment of Human Bone Quality, In Vivo, Using Spatially Offset Raman Spectroscopy

Sponsor

University College, London

Status

UNKNOWN

Phase

Detailed source ingestion pending

Condition raw

Osteoarthritis, Osteoporosis, Osteogenesis Imperfecta, Rickets / Osteomalacia, Bone Infection

Condition normalized

Osteoarthritis, Osteoporosis, Osteogenesis Imperfecta, Rickets / Osteomalacia, Bone Infection

Modality raw

medical device

Modality normalized

medical device

Target raw

spatially offset Raman spectrometer (SORS)

Target normalized

spatially offset Raman spectrometer (SORS)

Interventions

spatially offset Raman spectrometer (SORS)

Public preview

Source record

In this study spatially offset Raman spectroscopy (SORS), which allows the collection of Raman spectra through turbid media, is being applied to collect Raman spectra of bone. The principal aim to find ways to use Raman spectroscopy to assess bone quality in vivo.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Development of a Novel, Safe Method for the Non-invasive Assessment of Human Bone Quality, In Vivo, Using Spatially Offset Raman Spectroscopy

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02814591

Status

UNKNOWN

Phase

N/A

Sponsor

University College, London

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedNov 23, 2022

Internal syncJun 11, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02814591

Indication

Osteoarthritis

Modality

medical device

Target

spatially offset Raman spectrometer (SORS)

Intervention

spatially offset Raman spectrometer (SORS)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.